On Sep 16, 2021 IASO Biotherapeutics closed a Series C round and raised $108,000,000 from CCB International, CDH Investments, CNCB Capital, Co-Stone Venture Capital, Everbright, […]
Series B – 54gene
On Sep 16, 2021 54gene closed a Series B round and raised $25,000,000 from Adjuvant Capital, Cathay Innovation, Endeavor Catalyst, Ingressive Capital, KdT Ventures, Plexo […]
Grant – Rhaeos
On Sep 16, 2021 Rhaeos closed a Grant round and raised $4,000,000 from National Institute of Neurological Disorders and Stroke, featuring lead investors National Institute […]
Series B – Amolyt Pharma
On Sep 16, 2021 Amolyt Pharma closed a Series B round and raised $80,000,000 from Andera Partners, ATEM Capital, Bpifrance, Credit Agricole Entreprises, Eurazeo, Kurma […]
Series B – 54gene
On Sep 16, 2021 54gene closed a Series B round and raised $25,000,000 from Adjuvant Capital, Cathay Innovation, Endeavor Catalyst, Ingressive Capital, KdT Ventures, Plexo […]
Agena Bioscience acquired by Mesa Laboratories
Sep 14, 2021 Mesa Laboratories has entered into an agreement to acquire Agena Bioscience in a $300,000,000 deal. Mesa Laboratories based at Lakewood, Colorado, United […]
Series B – Vanqua Bio
On Sep 14, 2021 Vanqua Bio closed a Series B round and raised $85,000,000 from Avoro Ventures, Eli Lilly, Omega Funds, OrbiMed, OUP (Osage University […]
Series D – AgBiome
On Sep 14, 2021 AgBiome closed a Series D round and raised $116,000,000 from Blue Horizon, Novalis LifeSciences, featuring lead investors Blue Horizon, Novalis LifeSciences. […]
Post-IPO Equity – Avalo Therapeutics
On Sep 14, 2021 Avalo Therapeutics closed a Post-IPO Equity round and raised $27,500,000 from investors, featuring lead investors . About the company: Avalo Therapeutics […]
Post-IPO Equity – Virpax Pharmaceuticals
On Sep 14, 2021 Virpax Pharmaceuticals closed a Post-IPO Equity round and raised $40,000,000 from investors, featuring lead investors . About the company: Virpax Pharmaceuticals […]
